OxTalks is Changing
OxTalks will soon move to the new Halo platform and will become 'Oxford Events.' There will be a need for an OxTalks freeze. This was previously planned for Friday 14th November – a new date will be shared as soon as it is available (full details will be available on the Staff Gateway).
In the meantime, the OxTalks site will remain active and events will continue to be published.
If staff have any questions about the Oxford Events launch, please contact halo@digital.ox.ac.uk
Population health impact of new medicines recommended by NICE in England, 2000-2020
Health systems experience difficult trade-offs when paying for new drugs. In England, funding recommendations by the National Institute for Health and Care Excellence (NICE) for new drugs might generate health gains, but inevitably result in foregone health as the funds cannot be used for alternative treatments and services. We evaluated the population-health impact of NICE recommendations for new drugs during 2000-20. NHS coverage of new drugs displaced more population health than it generated. Our results highlight the inherent trade-offs between individuals who directly benefit from new drugs and those who forgo health due to the reallocation of resources towards new drugs.
This seminar is hosted in person and online, to join via Zoom, please use the details below:
zoom.us/j/93598736019?pwd=tHJ65nmXIrmYTUhi7YRbbdlnyi5Ie6.1
Meeting ID: 935 9873 6019
Passcode: 897963
Date:
25 February 2025, 9:30
Venue:
Department of Psychiatry, Headington OX3 7JX
Venue Details:
Seminar Room
Speaker:
Dr Huseyin Naci (London School of Economics and Political Sciences)
Organising department:
Department of Psychiatry
Organiser:
Rania Elgarf (Department of Psychiatry, University of Oxford)
Organiser contact email address:
rania.elgarf@psych.ox.ac.uk
Part of:
Psychiatry Seminar Series
Booking required?:
Not required
Audience:
Public
Editor:
Rania Elgarf
